Calling intismeran a cancer vaccine is catchy and makes some sense, but it lacks precision. Moderna and Merck are describing ...

Christine Johnston says biosimilar interchangeability bills, plus 2026 PBM reforms, would force PBMs to justify preferring higher-cost brands. Proposed legislation that would make approved biosimilars ...

Ty Gluckman, M.D., says the 2026 dyslipidemia guideline brings back risk-based LDL goals, and clinical inertia, not access, ...

The chief pharmacy officer role has changed significantly over the past five years, shifting away from running operations and ...

Ty Gluckman, M.D., says undertesting and undertreatment are the biggest gaps in lipid care and calls on leaders to invest in ...

Prescription drugs posted the largest spending increase among the four service categories examined in the Health Care Cost ...

Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B ...

Vision impairment affected 17.6% of 1,484 adult burn survivors in a study presented at AAO 2026, with age the strongest ...

As with the PubMed results, the verdict on whether weekend admission and care is associated with worse outcomes than their ...

Chad Hatfield, Pharm.D., of UC Davis Health, says rebate model readiness starts with a spend review and data that pharmacy ...

Robotic lobectomies grew from 49% to 70% of cases from 2020 to 2024 as access and training expanded, says Staci Beamer, M.D., ...

Healthcare spending for employer-insured Americans rose by nearly 19%between 2019 and 2023, driven by higher prices, surging ...